E. Jay Wilusz

E. Jay Wilusz

Patent Attorney, Attorney at Law

Quincy
Massachusetts
Licensed in
NJ, WA, Patent Bar
Seton Hall University School of Law

"Easy communication, Very Knowledgeable Attorney!"

5.0 5
Clear Communication
Response Time
Knowledgeable
Meets Deadlines
out of 22 reviews
About
I secure IP rights, transactions, and agreements to create optimal products and innovative partnerships. Strategic Patent Attorney with expertise in biotech, chemical, consumer product, and mechanical subject matter IP protection and business development. Previous US Head of Novartis Pharma IP group and Sanofi Life Cycle Management. Increased the value of over 100 products by more than 1 Billion USD. Resolves complex matters rapidly for maximum return on investment. Clearly conveys legal and technical concepts to a range of clients that include chief company officers, investors, and scientists.
16
Repeat
clients
52
Projects on
upcounsel
26
Years
experience
A few hours
Response Time
Contact E. Jay

Representative Clients

Practice Areas

Main Areas of Focus
Patents
Patents
  • Design Patent
  • Non-Provisional Patent
  • Patent Infringement
  • Patent Search
  • Provisional Patent
  • Response to USPTO Office Action (Patent)
  • Other Patent Matter
Trademarks & Copyrights
Trademarks & Copyrights
  • Response to USPTO Office Action (Trademark)
  • Trademark Registration
  • Trademark Search
  • Other Trademark & Copyright Matter
Commercial Contracts
Commercial Contracts
  • Affiliate Agreement
  • Business Consulting Agreement
  • Distribution Agreement
  • Equipment Lease
  • Licensing Agreement
  • Manufacturing Agreement
  • Marketing Agreement
  • Non-Disclosure Agreement (Commercial)
  • Release of Liability
  • SaaS Agreement
  • Sales Agreement
  • Service Agreement
  • Other Commercial Contract Matter
Other Practice Areas
Lawsuits & Disputes
Lawsuits & Disputes
  • Mediation
  • Settlement Agreement
  • Other Lawsuits & Disputes Matter
Legal Research & Writing
Legal Research & Writing
  • Brief
  • Case Law Research
  • Letter of Intent
  • Memo
  • Other Legal Research & Writing Matter
Mergers & Acquisitions
Mergers & Acquisitions
  • Asset Purchase
  • Asset Purchase Agreement
  • Spin-offs
  • Other Mergers & Acquisitions Matter
Outside General Counsel
Outside General Counsel
  • Outside General Counsel

Client Reviews

5.0
Clear Communication
Response Time
Knowledgeable
Meets Deadlines
out of 22 reviews
Clear Communication
Response Time
Knowledgeable
Meets Deadlines

"I am pleased with the high quality of Jay's work."


Posted on Jan 4, 2018
Clear Communication
Response Time
Knowledgeable
Meets Deadlines

"Easy communication, Very Knowledgeable Attorney!"

Assist with Patent Filing
Posted on Dec 10, 2017
Clear Communication
Response Time
Knowledgeable
Meets Deadlines

"Good experience. Will continue to use his service."

Draft Response to USPTO Office Action (Patent)
Posted on Oct 24, 2017
Clear Communication
Response Time
Knowledgeable
Meets Deadlines

"Would highly recommend Jay and will use him again if the circumstances call for it. Not only does he have a lot of knowledge and experience, but is also pleasant and easy to talk to."

Patent Infringement Services
Posted on Sep 5, 2017
Clear Communication
Response Time
Knowledgeable
Meets Deadlines

"I would hire Jay again."

Respond to Office Action
Posted on Aug 23, 2017
Clear Communication
Response Time
Knowledgeable
Meets Deadlines

"I would hire Jay again."

Respond to Office Action
Posted on Aug 21, 2017
View more reviews

Work History

EJW Pharma Strategy LLC

Principal and Founder

Jul 2012 - Present

• Advise pharma companies on business development, IP, regulatory, and licensing strategies.
• Design and implement IP, legal, marketing, business development and regulatory opportunities for Life Science products.
• Completed license deal of multiple products for 400 MM USD for a top 5 global Life Science company.
• Implement new development and marketing plans for Sanofi TB drug, Priftin®.

Jul 2012 - Present

Sanofi

US Life Cycle Management Oncology and Multiple Sclerosis Franchises Lead

Oct 2010 - Jun 2012

• Led teams of multi-functional experts to develop exclusivity for Aubagio®, Lemtrada®, Jevtana®, and Elitek®, via indications, drug delivery, drug repurposing and adherence projects.
• Appraised biotechnology and asset values for the acquisition of Genzyme.
• Implemented biotech strategy and due diligence for US and EU product development and marketing.
• Negotiated licensing agreement terms.

Oct 2010 - Jun 2012

Novartis Pharmaceuticals

Vice President, Pharma Regions Counsel, No. & So. America & Japan, Pharma IP Dept.

Jun 2001 - Aug 2010

• Obtained product patent protection, asset licenses, IP rights and rendered opinions for products with sales of 15+ Billion USD.
• Successful litigation outcome for products worth 1+ Billion USD.
• Negotiated IP protection and exclusivity with government entities and organizations in US, CA, LatAm and Japan.
• Implemented strategy, initiatives, and financial controls for 25 member IP staff.

Jun 2001 - Aug 2010
Publications on UpCounsel
How Long Does a Patent Last?
Article - 2017
Provisional Patent: Everything You Need to Know
Article - 2014

Want to work with
E. Jay Wilusz?

Contact E. Jay
Share E. Jay's profile link
Add E. Jay's profile link to your blog, or share it on social media.